IL245139B - Vaginal inserted estradiol pharmaceutical compositions and methods - Google Patents

Vaginal inserted estradiol pharmaceutical compositions and methods

Info

Publication number
IL245139B
IL245139B IL245139A IL24513916A IL245139B IL 245139 B IL245139 B IL 245139B IL 245139 A IL245139 A IL 245139A IL 24513916 A IL24513916 A IL 24513916A IL 245139 B IL245139 B IL 245139B
Authority
IL
Israel
Prior art keywords
methods
pharmaceutical compositions
vaginal
estradiol pharmaceutical
vaginal inserted
Prior art date
Application number
IL245139A
Other languages
Hebrew (he)
Other versions
IL245139A0 (en
Inventor
Brian A Bernick
Janice Louise Cacace
Peter H R Persicaner
Julia M Amadio
Thorsteinn Thorsteinsson
Frederick D Sancilio
Irani Neda
Original Assignee
Therapeuticsmd Inc
Brian A Bernick
Janice Louise Cacace
Peter H R Persicaner
Julia M Amadio
Thorsteinn Thorsteinsson
Frederick D Sancilio
Irani Neda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/099,562 external-priority patent/US8987237B2/en
Priority claimed from PCT/US2014/061811 external-priority patent/WO2015073177A1/en
Application filed by Therapeuticsmd Inc, Brian A Bernick, Janice Louise Cacace, Peter H R Persicaner, Julia M Amadio, Thorsteinn Thorsteinsson, Frederick D Sancilio, Irani Neda filed Critical Therapeuticsmd Inc
Publication of IL245139A0 publication Critical patent/IL245139A0/en
Publication of IL245139B publication Critical patent/IL245139B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
IL245139A 2013-10-22 2016-04-14 Vaginal inserted estradiol pharmaceutical compositions and methods IL245139B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361894411P 2013-10-22 2013-10-22
US14/099,562 US8987237B2 (en) 2011-11-23 2013-12-06 Natural combination hormone replacement formulations and therapies
US201461932140P 2014-01-27 2014-01-27
PCT/US2014/061811 WO2015073177A1 (en) 2013-10-10 2014-10-22 Vaginal inserted estradiol pharmaceutical compositons and methods

Publications (2)

Publication Number Publication Date
IL245139A0 IL245139A0 (en) 2016-06-30
IL245139B true IL245139B (en) 2020-08-31

Family

ID=55697531

Family Applications (1)

Application Number Title Priority Date Filing Date
IL245139A IL245139B (en) 2013-10-22 2016-04-14 Vaginal inserted estradiol pharmaceutical compositions and methods

Country Status (8)

Country Link
EP (1) EP3060179A4 (en)
JP (1) JP6680672B2 (en)
KR (2) KR102335160B1 (en)
AU (3) AU2014349132A1 (en)
BR (1) BR112016009008B8 (en)
IL (1) IL245139B (en)
MX (1) MX2022002614A (en)
RU (1) RU2713888C2 (en)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739558B1 (en) * 1995-10-05 1997-11-28 Innothera Lab Sa UNITAL GALENIC FORM FOR LOCAL HORMONOTHERAPY OF VAGINAL DROUGHT
FR2759292B1 (en) * 1997-02-10 2000-08-11 Cird Galderma USE OF RETINOIDS AS PIGMENTATION INDUCING AGENTS
WO1999022680A1 (en) * 1997-11-03 1999-05-14 Deschutes Medical Products, Inc. Pessary with medicated cartridge
JP2002510336A (en) * 1998-04-11 2002-04-02 エレカッパ・ユウロテラピッチ・ソシエタ・ペル・アチオニ Pharmaceutical preparations containing water-soluble ketoprofen salts and methods of using the same
MXPA04003866A (en) * 2001-11-09 2004-07-08 Pharmacia Ab Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder.
AU2003290071A1 (en) * 2002-12-18 2004-07-09 Ferrer Internacional, S.A. Pharmaceutical compositions of sertaconazole for vaginal use
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
MX2008001687A (en) * 2005-08-12 2008-02-19 Drugtech Corp Estrogen compositions and therapeutic methods of use thereof.
EP1872775A1 (en) * 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
LT2782584T (en) * 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2013112947A1 (en) * 2012-01-26 2013-08-01 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20130224268A1 (en) * 2012-02-27 2013-08-29 Newgen Biopharma Corp. Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same

Also Published As

Publication number Publication date
KR20210148435A (en) 2021-12-07
AU2019204658B2 (en) 2021-05-20
RU2016118396A3 (en) 2018-07-17
MX2022002614A (en) 2022-04-11
KR20160062097A (en) 2016-06-01
BR112016009008A2 (en) 2017-08-01
AU2021218231A1 (en) 2021-09-09
AU2019204658A1 (en) 2019-07-18
BR112016009008B8 (en) 2023-01-31
JP6680672B2 (en) 2020-04-15
JP2016534025A (en) 2016-11-04
RU2713888C2 (en) 2020-02-10
KR102488424B1 (en) 2023-01-12
RU2016118396A (en) 2017-11-28
EP3060179A4 (en) 2017-05-17
IL245139A0 (en) 2016-06-30
KR102335160B1 (en) 2021-12-03
AU2014349132A1 (en) 2016-04-14
EP3060179A1 (en) 2016-08-31
BR112016009008B1 (en) 2022-09-06
AU2014349132A8 (en) 2016-07-14

Similar Documents

Publication Publication Date Title
IL273205A (en) Compositions and methods
HK1218837A1 (en) Compositions and methods
HK1218560A1 (en) Compositions and methods
ZA201602510B (en) Strigolactone formulations and uses thereof
HK1223975A1 (en) Nanobubble-containing composition and use thereof
GB2533892B (en) Compositions and methods
IL286759A (en) Therapeutic methods and compositions
EP2815746A4 (en) Saponin nano-micelle and preparation method, use and pharmaceutical composition thereof
HUE044893T2 (en) Refractory formulation and use thereof
GB201317286D0 (en) Composition and Use
HK1220920A1 (en) Therapeutic compositions and uses thereof
GB201305813D0 (en) Compositions and methods
IL246167A0 (en) Berberine formulations and uses thereof
HK1219691A1 (en) Pharmaceutical composition and uses thereof
EP2968698A4 (en) Compounds and compositions for drug release
GB201318151D0 (en) Composition and device
IL259884A (en) Vaginal inserted estradiol pharmaceutical compositions and methods
IL245139B (en) Vaginal inserted estradiol pharmaceutical compositions and methods
GB201319255D0 (en) Therapeutic compositions and methods
GB201322617D0 (en) Methods and compositions
GB201322467D0 (en) Composition and use
GB201312393D0 (en) Compositions and Methods

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed